SBA
GSK icon

Secrest Blakey & Associates’s GSK GSK Stock Holding History

Secrest Blakey & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,657
Closed -$215K – 62
2019
Q4 		$215K Buy
+3,657
New +$203K 0.47% 54
2018
Q3 		– Sell
-3,994
Closed -$204K – 113
2018
Q2 		$204K Buy
+3,994
New +$201K 0.16% 102

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Secrest Blakey & Associates's GSK Position: Q1 2020 in Review

Secrest Blakey & Associates sold out of GSK (GSK) in Q1 2020, closing a stake of 3,657 shares — an estimated $215K sold.

Secrest Blakey & Associates first reported a position in GSK in Q2 2018 and held it in 2 quarters. The position peaked at $215K in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Secrest Blakey & Associates reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Secrest Blakey & Associates sold 3,657 GSK shares in Q1 2020, an estimated $215K.
  • Secrest Blakey & Associates first reported a position in GSK in Q2 2018 and held it in 2 quarters.
  • Secrest Blakey & Associates's GSK position peaked at $215K in Q4 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Secrest Blakey & Associates's 13F filing for Q1 2020, filed 24 Apr 2020.